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Abstract
Background: The activity of eukaryotic DNA polymerase delta (Pol δ) plays an essential role in genome stability through
its effects on DNA replication and repair. The p125 catalytic subunit of Pol δ is encoded by POLD1 gene in human cells.
To clarify biological functions of POLD1, we investigated the effects of POLD1 overexpression or downregulation on cell
proliferation, cell cycle progression, DNA synthesis and oxidative DNA damage induced by H2O2.
Methods: HEK293 cells were transfected with POLD1 expression plasmid or shRNA, cell proliferation, cell cycle
progression, and DNA synthesis in HEK293 cells were analyzed.
Results: HEK293 cells were transfected with POLD1 expression plasmid or shRNA. POLD1 downregulation by shRNA
suppressed cell proliferation, cell cycle progression, and DNA synthesis in HEK293 cells. However, POLD1 overexpression
had no significant effects on these processes. Finally, comet assay showed that POLD1 downregulation led to increased
DNA damage.
Conclusions: Our results suggest that human POLD1 plays important role in the regulation of cell cycle progression and
DNA damage repair.
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Background
Maintaining the integrity of DNA is dependent on the
fidelity of DNA replication and is essential for the
survival of cells and organisms. DNA polymerases are
absolutely essential to the eukaryotic replication process
[1]. DNA polymerase delta (Pol δ) plays an important
role in genome maintenance through its involvement
in replicative DNA synthesis and multiple synthetic
repair processes [2]. DNA Pol δ has intrinsic 3’ to
5’exonuclease activity, which is fundamental to the
function of the enzyme, and the interaction of DNA
Pol δ with proliferating cell nuclear antigen (PCNA)
allows it to replicate DNA processively [3].
Human DNA Pol δ is a multi-subunit complex
comprised of four subunits: p125, p68, p50, and p12 [4].
The p125 subunit has been identified as the catalytic
subunit and is encoded by the POLD1 gene in human
[5]. The polymerase and 3′-5′- exonuclease active sites
of Pol δ reside in the p125 subunit [6]. Previous studies
have shown that reducing the expression of the p125
subunit is sufficient to induce genomic instability, as
reduced expression of the p125 subunit in yeast resulted
in errors in DNA replication [7]. Another study linked
lower expression of p125 subunit to fragile site instability in
yeast, presumably by the induction of double-strand breaks
at stalled replication forks [8]. Moreover, the age-related
decrease in POLD1 expression has been shown to be
involved in the classical DNA repair pathway in vitro [9].
Furthermore, these was an inverse correlation between
POLD1 expression and age both in vivo and in vitro
[10]. These data suggest that POLD1 may be associated
with aging. However, how human POLD1 is involved in
senescence-related processes remains unclear.
In the present study, we used HEK293 cells as the model
to investigate the role of human POLD1 in senescence-
related processes, including cell proliferation, cell cycle
progression, DNA synthesis, and oxidative stress-induced
DNA damage.
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HeLa cells and HEK293 cells were purchased from Shanghai
Cell Institute Country Cell Bank. All cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM, Life Tech-
nologies, USA) supplemented with 10 % fetal bovine serum
(FBS, Life Technologies) in a humidified incubator with
5 % CO2 at 37 °C. The medium was replaced every 2 days,
and cells were passaged once. Exponentially growing
cells were selected for the experiments.
Plasmids and shRNAs
To construct a plasmid for the overexpression of POLD1,
POLD1 cDNA was isolated from HeLa cells. The full-length
POLD1 cDNA (GenBank accession number M80397) was
amplified by polymerase chain reaction (PCR) using
the following primers: 5’-CGCGGATCCCTGTGGCGG
GAAACGCTGTTTGAAG-3’ and 5’- CAACAAGCTTCA
AGGTCACCAGGCCTCAGGTCCAG-3’, and subcloned
into pcDNA3.0 to construct pcDNA3.0-POLD1. Positive
clones were confirmed by DNA sequencing.
Short hairpin RNA (shRNA) targeting POLD1 (shPOLD1)
and the negative control shRNA (shControl) were
purchased from BGI (Shenzhen, China). The oligonu-






HEK293 cells were seeded in 6-well culture plates 1 day
before transfection. POLD1 plasmid and shRNA as well
as negative controls were transfected into HEK293 cells
using Lipofectamine 2000 (Life Technologies) according
to the manufacturer’s instructions. At 48–72 h after
transfection, the cells were collected for further analysis.
Quantitative real-time reverse transcription PCR
Total RNA was isolated from cells using a UNIQ-10
Column Total RNA Purification Kit (Sangon Biotech,
Shanghai, China) and quantified using a NanoDrop 2000
UV–vis spectrophotometer (Thermo Fisher Scientific,
USA). RNA was reverse transcribed using a One Step
PrimeScript cDNA Synthesis kit (Takara, Japan). The
POLD1 sense primer was 5′- CAACCTGGTCACTGCC
TCAC-3′, and the antisense primer was 5′- GTCCCG
CTTCCTCATCCTCT-3′. For the β-actin gene, the sense
primer was 5′-GCTCAGGAGGAGCAATGATCTTG-3′,
and the antisense primer was 5′-GTACGCCAACACA
GTGCTGTC-3′. Real-time PCR analysis was performed in
an ABI 7500 FAST Real-Time PCR System (Applied
Biosystems, CA, USA) using SYBR Green (Takara). Relative
expression levels were calculated using the 2−ΔΔCt method
and quantified after normalization to β-actin. Each experi-
ment was performed in triplicate and repeated three times.
Western blot analysis
Cells were lysed in RIPA lysis buffer (Beyotime, Nanjing,
China) containing the protease inhibitor phenylmethanesul-
fonyl fluoride (Beyotime). Protein concentrations were
determined using a BCA Protein Assay kit (Tiangen, Beijing,
China). Equal amounts of protein were loaded on polyacryl-
amide gels and separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. Proteins were then
transferred to polyvinylidene fluoride membranes (Millipore,
Billerica, MA, USA). Membranes were blocked with 5 % w/
v nonfat dry milk in Tris-buffered saline containing Tween
20 (TBST: 20 mM Tris–HCl pH7.8, 150 mM NaCl, and
0.05 % Tween 20) for 1 h at room temperature. The blots
were then incubated with antibodies against POLD1 (1:1000
dilution; Abcam, UK) and GAPDH (1:2000 dilution;
GenScript, USA) at 4 °C overnight. After incubation with
the corresponding horseradish peroxidase (HRP)-conjugated
secondary antibodies, protein bands were visualized using a
SuperSignal West Pico kit (Thermo Fisher Scientific). Densi-
tometric analysis of protein bands was performed using
Image Lab software (Bio-Rad, Hercules, CA, USA).
Cell proliferation assay
The proliferation of HEK293 was assessed using a Cell
Counting Kit-8 detection kit (CCK-8; Beyotime). Briefly,
cells were seeded in triplicate in 96-well plates at 5 ×
103 cells/well. Adherent cells were transfected with
pcDNA3.0-POLD1, pcDNA3.0, shPOLD1, or shControl.
At 24, 48, and 72 h after transfection, 10 μL CCK-8
solution was added to each well, and plates were then
incubated for 2 h at 37 °C. Absorbance values of all
wells were then determined at 450 nm in a Microplate
Reader (Thermo Fisher Scientific).
Cell cycle analysis
Cell cycle was analyzed using flow cytometry with propi-
dium iodide (PI) staining. Briefly, 48 h after transfection,
HEK293 cells (2 × 106 for each sample) were harvested in
triplicate. After washing twice with cold phosphate-buffered
saline (PBS), the cells were resuspended in 70 % ethanol
and fixed overnight at 4 °C. Next, the fixed cells were
washed with PBS and incubated with RNase A and PI at
37 °C for 30 min in the dark. The cell cycle distribution was
then analyzed by flow cytometry (BD Biosciences, USA).
5-Ethynyl-2′-deoxyuridine (EdU) incorporation assay
DNA synthesis was assessed by the incubation of cells with
10 μM EdU for 30 min, followed by staining according to
the manufacturer’s recommendations (RiboBio, Guangzhou,
China). Cells were then harvested and analyzed by flow
cytometry (BD Biosciences).
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Comet assay
At 48 h after transfection, HEK293 cells were treated
with 150 μM H2O2 for 5 min at 4 °C in the dark. Cells
were then washed with PBS and immediately analyzed
using comet assay as previously described [9]. Data were
analyzed using CASP software (CASP-1.2.2), and the
Olive tail moment (OTM) was measured.
Statistical analysis
Statistical analysis was performed using SPSS 13.0
software (SPSS Inc., Chicago, IL, USA). Values were
presented as means ± standards error (SEs). Comparisons
between groups were performed by one-way analysis of
variance (ANOVA) followed by post-hoc Tukey analysis.
P values of less than 0.05 were considered statistically
significant.
Results
Overexpression or downregulation of POLD1 in HEK293
cells
First, we introduced POLD1 expression vector or POLD1
shRNA into HEK293 cells, using pcDNA3.0 and shControl
plasmids as negative controls. qRT-PCR analysis demon-
strated that POLD1 mRNA level was increased over
Fig. 1 Modulation of POLD1 expression in HEK293 cells. a qRT-PCR analysis of POLD1 mRNA level in HEK293 cells transfected with
pcDNA3.0-POLD1, pcDNA3.0, shPOLD1 or shControl. b Western blot analysis of POLD1 protein level in HEK293 cells transfected with
pcDNA3.0-POLD1, pcDNA3.0, shPOLD1 or shControl. Untransfected HEK293 cells were used as a control (Blank). n = 3, *P < 0.01 vs. the negative control
(pcDNA3.0 or shControl)
Fig. 2 Effects of altered POLD1 expression on the growth of HEK293 cells. HEK293 cells were transfected with the indicated vectors, and cell
proliferation was determined by CCK-8 assay 24, 48, and 72 h later. Data shown were the mean ± SD of the ratio for the absorbance at 450 nm.
n = 3, *P < 0.01 vs. shControl
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4000-fold in HEK293 cells transfected with pcDNA3.0-
POLD1, compared to control (Fig. 1a). Conversely, POLD1
mRNA level was decreased by 50 % following transfection
with shPOLD1, compared to control (Fig. 1a). Western
blot analysis confirmed that POLD1 protein level was sig-
nificantly increased following transfection with pcDNA3.0-
POLD1 (P < 0.01), but was significantly downregulated
following transfection with shPOLD1 (P < 0.01), compared
with the respective negative controls (Fig. 1b). Taken
together, these data indicate that using plasmids or shRNA
we constructed, we could effectively overexpress or down-
regulate POLD1 in HEK293 cells.
POLD1 shRNA inhibits the proliferation of HEK293 cells
CCK-8 assay showed that the proliferation of HEK293
cells was significantly inhibited after transfection with
shPOLD1 compared to cells transfected with shControl
(P < 0.01). However, overexpression of POLD1 did not
significantly alter cell proliferation compared with the
control (P > 0.05) (Fig. 2).
POLD1 shRNA leads to cell cycle arrest in HEK293 cells
Since POLD1 shRNA suppressed the proliferation of
HEK293 cells, we wondered whether these changes are
associated with the regulation of cell cycle progression.
Thus, we analyzed cell cycle distribution by flow cytometry
analysis in HEK293 cells following transient transfection
with pcDNA3.0-POLD1, pcDNA3.0, shPOLD1, or shCon-
trol. We found that the percentages of cells in G1 and G2/
M phases were increased after transfection with shPOLD1,
compared to the control. Although the increases were
small, they showed significant differences (P < 0.05).
Fig. 3 Effects of altered POLD1 expression on e cell cycle progression of HEK293 cells. a Representative FACS plots showing cell cycle
distribution of HEK293 cells transfected with the indicated vectors. b Quantification of the percentage of cells in different phases. n = 3,
*P < 0.01 vs. shControl
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However, overexpression of POLD1 by transfection with
pcDNA3.0-POLD1 did not affect the cell cycle distribution
compared to the control (Fig. 3). Taken together, these
results demonstrate that POLD1 shRNA inhibits cell cycle
at both G1 and G2/M phases in HEK293 cells.
POLD1 shRNA reduces the rate of DNA synthesis in
HEK293 cells
To further investigate the role of POLD1 in HEK293 cell
proliferation, we performed EdU incorporation assay.
Compared with shControl-transfected cells, shPOLD1-
transfected cells exhibited a 30 % reduction in the rate
of EdU incorporation. Consistent with the results of cell
cycle analysis, there was no significant difference in
DNA synthesis following transfection with pcDNA3.0-
POLD1 compared with the control (Fig. 4). Collectively,
these data suggest that POLD1 downregulation leads to
attenuated DNA synthesis in HEK293 cells.
POLD1 shRNA increases oxidative DNA damage in
HEK293 cells
Since DNA Pol δ plays important roles in DNA damage re-
pair, we examined whether POLD1 could protect HEK293
cells against oxidative DNA damage. By comet assay we
found that there were no differences in DNA damage
among HEK293 cells transfected with pcDNA3.0-POLD1
or pcDNA3.0, after treatment with 150 μM H2O2.
However, POLD1 shRNA led to increased DNA damage
in HEK293 cells after treatment with 150 μM H2O2, com-
pared to control shRNA transfected cells (Fig. 5). These
data suggest that POLD1 shRNA impairs DNA damage
repair in HEK293 cells.
Fig. 4 Quantification of DNA synthesis rate in HEK293 cells. a HEK293 cells were transfected with the indicated vectors, 48 h after transfection
EdU-positive cells were determined by flow cytometry. b Quantification of the percentage of cells positive for EdU incorporation assay shown in
(a). n = 3, *P < 0.01 vs. shControl
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Discussion
Cell proliferation plays an essential role in senescence
[11, 12]. In the present study, we found that the down-
regulation of POLD1 gene, which encodes the catalytic
subunit of DNA Pol δ, markedly inhibited cell prolifera-
tion. Further analysis showed that the inhibition of cell
proliferation following POLD1 downregulation was related
to the inhibition of cell cycle progression and DNA synthe-
sis. Interestingly, we found that POLD1 overexpression
had no significant effects on cell proliferation, cell cycle
progression and DNA synthesis. We think that endogen-
ous POLD1 may be enough to regulate these processes
and exogenous overexpression of POLD1 could not
achieve additional effects. Collectively, our data suggest
that POLD1 promotes cell proliferation by regulating cell
cycle and DNA synthesis.
In mammals, cell proliferation and cell cycle progression
are tightly regulated processes, and loss of expression of
specific genes encoding proteins essential for DNA
synthesis may lead to mitotic dysregulation in senescent
cells [13]. POLD1 is a key component of DNA Pol δ
catalytic subunit and plays an important role in cell
growth and differentiation [14]. Previous studies have
indicated that replicatively senescent cell populations
arrest in both G1and G2 stages [15, 16]. In our study, we
found that POLD1 shRNA blocked cell cycle at G1 and
G2/M phases and resulted in reduced DNA synthesis.
These results provide new evidence for the potential role
of POLD1 in the regulation of cell cycle progression.
Studies have shown that the POLD1 promoter has
consensus sequences at the Sp1 and E2F binding sites
[6]. E2F is thought to be crucial for the G1/S transition
and DNA replication. Therefore, E2F may regulate POLD1
expression during cell cycle progression. Moreover, p53
represses Sp1-stimulated POLD1 promoter activity
[17, 18], and p21 blocks E2F1 release by binding to the
Fig. 5 Effects of altered POLD1 expression on DNA damage in HEK293 cells. a HEK293 cells were transfected with the indicated vectors and
treated with 150 μM H2O2 for 5 min in the dark. Comet assay was then performed, and images were acquired using a fluorescence microscope
to show DNA fragment migration patterns. b Quantification of the tail moments from the comet assay shown in (a). *P < 0.01, vs. the negative
control (shControl or shControl + H2O2)
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POLD1 promoter at the E2F1 binding site, thereby
inhibiting POLD1 activity [19]. These findings may
explain the mechanisms by which POLD1 is involved
in the regulation of cell proliferation.
During aging, free radicals and reactive oxygen species
(ROS) accumulate in cells and tissues. ROS generate a
variety of DNA lesions, including oxidized DNA bases,
abasic sites, single-strand breaks (SSBs), and double-
strand breaks (DSBs) [20]. Previous data indicate that
oxidative stress appears to play an essential role in the
process of premature aging [21]. Therefore, efficient
DNA repair in is very important to prevent cell aging.
The predominant repair pathways in mammalian cells
are base excision repair (BER), nucleotide excision repair,
DSB repair and mismatch repair [22, 23]. BER is a major
mechanism involved in the protection of cells from
mutagenic base damage spontaneously generated through
normal cellular metabolism or DNA damage caused by
exogenous agents, such as oxidative stress, hydrolysis, and
environmental factors. In addition to its crucial role in
DNA replication, DNA Pol δ plays an essential role in
DNA repair and is generally regarded as the primary
enzyme involved in resynthesis (gap filling) in various
DNA repair processes [24]. DNA Pol δ plays an important
role by modulating the rate of single-nucleotide BER and
long patch BER during the repair process [25]. Therefore,
we hypothesized that POLD1 could affect oxidative DNA
damage in HEK293 cells. Our results showed that POLD1
shRNA markedly resulted in increased DNA damage
induced by H2O2, potentially through inhibiting DNA
replication (leading to elevated DSBs) and DNA synthesis
associated with DNA repair. Our data suggest that POLD1
may provide protection against oxidative DNA damage
through various DNA repair systems.
However, secondary roles of POLD1 in other pathways
should be considered. It is possible that some unidentified
factors are activated following POLD1 downregulation
and contribute to the inhibition of cell proliferation and
increased DNA damage. Further studies are needed to
elucidate the mechanisms by which POLD1 regulates cell
cycle and DNA damage response.
Conclusions
In summary, we demonstrated that POLD1 downregula-
tion markedly inhibited cell proliferation by regulating
cell cycle and DNA synthesis. POLD1 downregulation also
resulted in increased DNA damage induced by H2O2.
Therefore, POLD1 plays an important biological role in
cell cycle regulation and DNA damage repair.
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